PDCD1 and neoplasm: Regarding the overexpression of tumor miR-21–3p increased the efficacy of anti-PD-1 immunotherapy in the preclinical mouse model, we proposed that systemic delivery of miR-21–3p to tumor tissue by AuNp might be of high translational potential to synergize with anti-PD-1 immunotherapy.